Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil + ciprofol versus alfentanil + remimazolam for sedation during fibreoptic bronchoscopy
ChiCTR2400082469Phase 4Not yet recruiting
- Sponsor
- Hangzhou Red Cross Hospital
- Start
- Mar 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alfentanil, ciprofol and remimazolam (2 arms), sponsored by Hangzhou Red Cross Hospital. Primary endpoints: Hypoxaemia, Hypertension during bronchoscopy and 3 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
alfentanilciprofolremimazolam
Beyond the preview
Go deeper on ChiCTR2400082469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082469.